Perfil
Kevin Harris is currently the Chief Commercial Officer at VectivBio Holding AG since 2019.
Prior to this, he worked at Incyte Corp.
for 10 years from 2009 to 2019, where he held the position of Group Vice President-Global Product Strategy from 2017 to 2019.
Mr. Harris completed his undergraduate degree at Cornell University and obtained an MBA from Kellogg School of Management.
Antiguos cargos conocidos de Kevin Harris.
| Empresas | Cargo | Fin |
|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 01/10/2019 |
| VECTIVBIO HOLDING AG | Corporate Officer/Principal | - |
Formación de Kevin Harris.
| Kellogg School of Management | Masters Business Admin |
| Cornell University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| Empresas privadas | 1 |
|---|---|
VectivBio Holding AG
 VectivBio Holding AG Pharmaceuticals: MajorHealth Technology VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. It operates through Switzerland, Canada, and the United States geographical segment. The company was founded by Luca Santarelli on May 22, 2019 and is headquartered in Basel, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Kevin Harris
